| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/03/2011 | WO2011013624A1 Indole derivative and pharmacologically acceptable salt thereof |
| 02/03/2011 | WO2011013623A1 Indole derivative and pharmacologically acceptable salt thereof |
| 02/03/2011 | WO2011013141A2 Substituted benzamide derivatives as glucokinase (gk) activators |
| 02/03/2011 | WO2011012674A1 Dihydrobenzoindazoles |
| 02/03/2011 | WO2011012622A1 Benzoxazinone derivatives for the treatment of glytl mediated disorders |
| 02/03/2011 | WO2011012577A1 Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases |
| 02/03/2011 | WO2011012321A1 Processes for crystallization of rivaroxaban |
| 02/03/2011 | WO2010131192A3 Novel oxazolidinone derivatives and their use as orexin receptor antagonists |
| 02/03/2011 | WO2010115491A3 Piperidine and piperazine derivatives as autotaxin inhibitors |
| 02/03/2011 | US20110028715 Novel adenine compound |
| 02/03/2011 | US20110028509 Sulfonamides |
| 02/03/2011 | US20110028506 Pharmaceutical Composition For Preventintion And Treatment Of Restenosis Comprising Isoxazole Derivatives |
| 02/03/2011 | US20110028501 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 02/03/2011 | US20110028493 Heterocyclic derivative and use thereof |
| 02/03/2011 | US20110028485 1,5-diphenylpyrazoles ii as hsp90 inhibitors |
| 02/03/2011 | US20110028482 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028478 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028476 Proton pump inhibitors |
| 02/03/2011 | US20110028474 Protein kinase and phosphatase inhibitors |
| 02/03/2011 | US20110028469 Thiphene-2-Carboxamide Derivatives As Modulators of CCR9 Receptor |
| 02/03/2011 | US20110028468 Compounds having npy y5 receptor antagonistic activity |
| 02/03/2011 | US20110028465 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/03/2011 | US20110028464 Inhibitors of human immunodeficiency virus replication |
| 02/03/2011 | US20110028463 Amide compounds |
| 02/03/2011 | US20110028461 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 02/03/2011 | US20110028455 Indole-substituted 3-cyanopyridines As Kinase Inhibitors |
| 02/03/2011 | US20110028451 Dihydrobenzoindazoles |
| 02/03/2011 | US20110028449 Novel aminomethyl benzene derivatives |
| 02/03/2011 | US20110028448 Pyridine compounds |
| 02/03/2011 | US20110028447 Indazole derivatives |
| 02/03/2011 | US20110028446 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 02/03/2011 | US20110028445 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 02/03/2011 | US20110028320 Compositions and methods for controlling nematodes |
| 02/03/2011 | US20110028318 Herbicidal compounds based on n-azinyl-n'-pyridylsulphonylureas |
| 02/03/2011 | CA2768904A1 Dihydrobenzoindazoles |
| 02/03/2011 | CA2768816A1 Indole derivative or pharmaceutically acceptable salt thereof |
| 02/03/2011 | CA2768814A1 Indole derivative or pharmaceutically acceptable salt thereof |
| 02/03/2011 | CA2768232A1 Substituted benzamide derivatives as glucokinase (gk) activators |
| 02/03/2011 | CA2767875A1 Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases |
| 02/03/2011 | CA2766515A1 Compounds for the reduction of .beta.-amyloid production |
| 02/02/2011 | EP2280006A1 Pharmaceutical composition for inhalation comprising an oxazole or thiazole m3 muscarinic receptor antagonist |
| 02/02/2011 | EP2280003A2 Process for preparing receptor-type kinase modulators |
| 02/02/2011 | EP2279169A2 Therapeutic compounds |
| 02/02/2011 | EP2278879A2 Compounds, compositions and methods comprising oxadiazole derivatives |
| 02/02/2011 | EP1485358B1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
| 02/02/2011 | CN101965346A Novel pyrimidine-pyridine derivatives |
| 02/02/2011 | CN101965345A Pyridine compounds |
| 02/02/2011 | CN101965344A Isoxazole-imidazole derivatives |
| 02/02/2011 | CN101965339A Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 02/02/2011 | CN101279972B Benzoxazole herbicides and preparation thereof |
| 02/02/2011 | CN101175725B Process for the preparation of opioid modulators |
| 02/01/2011 | US7880009 Cinnamide compound |
| 02/01/2011 | US7880000 N-(5-(1,1- dimethylethyl)-3- isoxazolyl)-4-methyl-3- ((3-(4-pyrimidinyl)-2- pyridinyl)amino)benzamide, used for treating breast cancer or rheumatoid arthritis |
| 02/01/2011 | US7879995 organic electroluminescent device has, between a pair of electrodes, at least one organic layer including a light-emitting layer, in which the organic layer contains a specific tetraphenylene compound |
| 02/01/2011 | US7879888 Thiazole derivatives and use thereof |
| 02/01/2011 | US7879880 Substituted aniline derivatives useful as histamine H3 antagonists |
| 02/01/2011 | US7879861 4-N-(3-bromophenyl)-6-N-(2-chloroethyl)quinazoline-4,6-diamine, capable of both inhibiting epidermal growth factor receptors and damaging DNA; antitumor and antiproliferative agents |
| 02/01/2011 | US7879856 Diaminothiazoles useful as Axl inhibitors |
| 02/01/2011 | US7879854 2-morpholin-4-ylethyl 5-[3-[(2S)-1-[4-(1-hydroxyhexyl)phenyl]-5-oxopyrrolidin-2-yl]propyl]thiophene-2-carboxylate, useful in treating vision defects, inflammatory bowel disease and alopecia |
| 02/01/2011 | US7879851 Viral polymerase inhibitors |
| 02/01/2011 | US7879850 Organic compounds |
| 02/01/2011 | US7879849 such as 1-(2-Methylpropyl)-2-propyl-2H-pyrazolo[3,4-c]quinolin-4-amine, used as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of viral and neoplastic diseases |
| 02/01/2011 | US7879848 Dipeptidyl Peptidase-IV inhibiting compounds, method of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 02/01/2011 | US7879846 Serine hydrolase inhibitors |
| 02/01/2011 | US7879838 Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity |
| 02/01/2011 | CA2630040C Heterocycle-substituted 3-alkyl azetidine derivatives |
| 02/01/2011 | CA2555633C Non-nucleoside reverse transcriptase inhibitors |
| 02/01/2011 | CA2481055C Combinations of quinolinone derivatives and 5-fu or cpt 11 |
| 02/01/2011 | CA2418656C Proline derivatives and use thereof as drugs |
| 02/01/2011 | CA2403424C Flavone derivatives, preparation method and use as medicines |
| 02/01/2011 | CA2315717C Inhibition of raf kinase using substituted heterocyclic ureas |
| 01/27/2011 | WO2011011303A1 Inhibitors of flaviviridae viruses |
| 01/27/2011 | WO2011011232A1 Dual-acting oxazole antihypertensive agents |
| 01/27/2011 | WO2011011123A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| 01/27/2011 | WO2011009943A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders |
| 01/27/2011 | WO2011009484A1 Arylpyrazoles and arylisoxazoles and their use as pkd modulators |
| 01/27/2011 | US20110021773 6-pyrimidinyl-pyrimid-4-one derivative |
| 01/27/2011 | US20110021771 Inhibitors of histone deacetylase |
| 01/27/2011 | US20110021573 Antagonists of prostaglandin d2 receptors |
| 01/27/2011 | US20110021549 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 01/27/2011 | US20110021531 Oxazole derivatives useful as inhibitors of faah |
| 01/27/2011 | US20110021528 Novel hydroxamates as therapeutic agents |
| 01/27/2011 | US20110021527 Dual-acting oxazole antihypertensive agents |
| 01/27/2011 | US20110021523 Aryl sulfonamides |
| 01/27/2011 | US20110021522 Activators of executioner procaspases 3, 6 and 7 |
| 01/27/2011 | US20110021521 Fused heterocyclic compounds as ion channel modulators |
| 01/27/2011 | US20110021520 Oxazine derivatives and their use in the treatment of neurological disorders |
| 01/27/2011 | US20110021519 Tetrahydropteridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021518 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase |
| 01/27/2011 | US20110021512 Cyclic Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1 |
| 01/27/2011 | US20110021498 Indolyl- pyridone derivatives having checkpoint kinase 1 inhibitory activity |
| 01/27/2011 | US20110021496 Thienopyrimidine derivatives as p13k inhibitors |
| 01/27/2011 | US20110021495 Quinazoles useful as modulators of ion channels |
| 01/27/2011 | US20110021489 Substituted piperidines |
| 01/27/2011 | US20110021487 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and their use |
| 01/27/2011 | US20110021486 Viral polymerase inhibitors |
| 01/27/2011 | US20110021479 Pyrrolopyrimidinecarboxamides |
| 01/27/2011 | US20110021462 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 01/27/2011 | US20110020376 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110020278 Inhibitors of flaviviridae viruses |